10 Signs of High-Functioning Depression at Work, Anchored in DSM-5-TR Criteria

High-functioning persistent depressive disorder commonly presents as a person who has “always been like this” and who can no longer remember what it felt like to feel different. Performance is intact. Internal weather has been overcast for so long it stops being noticed.

DSM-5-TR persistent depressive disorder requires depressed mood most of the day, more days than not, for at least two years, with at least two additional symptoms (poor appetite or overeating, insomnia or hypersomnia, low energy, low self-esteem, poor concentration, hopelessness)¹. Twelve-month prevalence estimates for dysthymia have been reported around 0.5%, with chronic major depressive disorder around 1.5%, and combined PDD prevalence considerably higher in some samples^1,2. First-line evidence-based treatment integrates psychotherapy (cognitive-behavioral, depth-oriented, or interpersonal) and psychiatric medication evaluation, often combined for sustained remission.

“Sunday scaries” pass when work begins. Sunday-night dread that does not lift is a different signal: anticipatory anxiety overlapping with depressive low energy and hopelessness, often a marker of either chronic work-related distress or underlying depression that work itself triggers.

Persistent anticipatory dread that does not resolve when the anticipated event begins suggests the work environment is functioning as a depressive trigger rather than a normal stressor. When paired with two or more PDD criteria sustained over months, it warrants a clinical evaluation rather than a generic time-management response¹. First-line treatment combines psychotherapy targeting the work-related cognitive and affective patterns with broader assessment for underlying mood disorder.

Anhedonia is one of the two cardinal DSM-5-TR symptoms of major depression. In high-functioning presentations it is most visible at the moment of achievement, when the expected internal lift simply does not arrive. The person performs the appropriate response and registers the disconnect privately.

DSM-5-TR major depressive disorder requires either depressed mood or anhedonia along with additional symptoms over a two-week period; persistent depressive disorder accommodates a longer chronic course¹. High-functioning depression often satisfies criteria but is missed clinically because functioning remains high. First-line treatment integrates evidence-based psychotherapy and psychiatric medication evaluation when criteria are met, with combined treatment showing better outcomes than either alone for many patients.

Meetings happen, deliverables ship, but the person reports running on routines, not motivation. Colleagues do not notice. Spouses sometimes do.

DSM-5-TR persistent depressive disorder explicitly accommodates clients whose role-functioning remains intact, and the consequences of PDD are increasingly recognized as severe over the long course¹. The gap between role performance and inner experience is part of why high-functioning depression is underdiagnosed at primary care, where 15-minute visits emphasize observable function. The pattern frequently progresses to a major depressive episode under stress if untreated. First-line evidence-based response is structured depression screening (PHQ-9), evidence-based psychotherapy, and psychiatric medication evaluation when criteria are met, with combined treatment showing improved outcomes for many patients.

Low energy is a DSM-5-TR criterion symptom for both PDD and major depression. When exhaustion outlasts rest, persists across vacation, and is not explained by medical workup, depression is on the differential.

Low energy is an explicit DSM-5-TR criterion symptom for both persistent depressive disorder and major depressive disorder¹. The clinical differential includes thyroid dysfunction, anemia, sleep apnea, vitamin D deficiency, chronic fatigue syndrome, and underlying mood disorder, which is why coordination with primary care is part of standard assessment. When medical workup is unremarkable and exhaustion persists, evidence-based depression treatment is the next step rather than indefinite further investigation. First-line response is psychotherapy plus psychiatric coordination as indicated, with PCP communication around medical differential ruled out.

Depression in adults often presents partly as irritability rather than sadness. The high performer reports being snappier, less patient, and more easily activated, without identifying any specific cause.

DSM-5-TR explicitly recognizes irritability as a presenting feature of depression in adults, not just in children and adolescents¹. In high-achiever populations, irritability often surfaces before sadness becomes accessible to introspection, partly because the cultural script for adults conflates sadness with weakness while irritability passes as personality. The pattern is frequently noticed first by spouses, partners, or family rather than by the depressed individual. First-line evidence-based response is structured depression screening that asks about irritability directly, paired with affect-focused psychotherapy and psychiatric medication evaluation when warranted.

DSM-5-TR depression criteria explicitly include insomnia or hypersomnia. In high-functioning depression, sleep onset is delayed, early-morning waking is common, and naps fail to restore. The pattern is often years old before it is named clinically.

Insomnia and hypersomnia are explicit DSM-5-TR criterion symptoms for both persistent depressive disorder and major depressive disorder, and early-morning awakening is a particularly characteristic feature of melancholic depression¹. Sleep architecture changes (reduced REM latency, decreased slow-wave sleep) are documented physiologic correlates of depressive states. Treating insomnia in isolation when underlying depression is present often produces partial response and recurrence. First-line evidence-based response is integrated treatment combining CBT-I (cognitive behavioral therapy for insomnia) with depression-targeted psychotherapy, and psychiatric medication evaluation when warranted.

High-functioning depression preserves the social load that produces output and quietly drops the social load that produces meaning. Friendships thin, family time becomes effortful, and the person attributes it to “being busy” rather than depression.

Social withdrawal is documented in DSM-5-TR depression criteria and behavioral activation literature as a maintaining factor that compounds depressive states over time¹. The pattern is particularly subtle in high-functioning clients because social load that produces output remains intact while social load that produces meaning quietly decreases. Untreated, this contributes to the loneliness and isolation patterns documented in executive populations and to predicted relapse rates after initial treatment. First-line evidence-based response is behavioral activation, interpersonal psychotherapy, and depth-oriented work to re-engage non-essential social contact as part of structured depression treatment.

High-achievers often live with a demanding inner voice that has been part of the engine of their performance. Depression frequently shifts that voice from demanding to contemptuous, with a tone of disgust, shame, or worthlessness that did not used to be there. The shift is rarely flagged because the inner voice has been criticized for so long that “harsher” feels like baseline.

Worthlessness and excessive guilt are explicit DSM-5-TR criterion symptoms for major depressive disorder, and self-critical content is a recognized cognitive feature of both MDD and persistent depressive disorder¹. The internal voice’s shift from challenge to contempt is clinically meaningful and often precedes overt depressive symptoms by months. CBT, IFS, and AEDP all engage the inner critic directly, with different mechanisms but converging effectiveness. First-line evidence-based response is structured depression assessment, evidence-based psychotherapy targeting the cognitive content, and psychiatric medication evaluation when criteria are met.

High-functioning clients often describe a quiet collapse of forward-looking emotion: the trip is booked, the milestone is approaching, the project is interesting on paper, and none of it produces felt anticipation. The future has become a logistical schedule rather than a felt arc.

Hopelessness and reduced future-orientation are documented features of major depressive disorder and persistent depressive disorder, with hopelessness specifically associated with elevated suicide risk in clinical assessment¹. The flattening is often subtle in high-achiever populations because role-driven activity continues regardless of internal anticipation. Comorbidities include anhedonia, social withdrawal, and irritability. First-line evidence-based response is structured depression assessment with explicit attention to hopelessness and suicidality, evidence-based psychotherapy, and psychiatric coordination when criteria are met.